Mainstream Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Mainstream Capital Management's AMGN Position: Q3 2026 in Review
Mainstream Capital Management opened a new position in Amgen (AMGN) in Q3 2026: 100 shares worth $42.2K. The stake represents 0.02% of the portfolio and ranks #150 among its holdings. This is a return to the name: Mainstream Capital Management previously reported a position in AMGN as recently as Q4 2024.
Mainstream Capital Management first reported a position in AMGN in Q4 2024 and has held it in 2 quarters since. The position peaked at $47.4K in Q4 2024. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Mainstream Capital Management held 100 shares of Amgen worth $42.2K as of Q3 2026.
- Amgen was a new Mainstream Capital Management position in Q3 2026.
- Amgen made up 0.02% of Mainstream Capital Management's portfolio in Q3 2026, its #150 holding.
- Mainstream Capital Management first reported a position in Amgen in Q4 2024 and has held it in 2 quarters since.
- Mainstream Capital Management's Amgen position peaked at $47.4K in Q4 2024.
- 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Mainstream Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.